• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

ORL J Otorhinolaryngol Relat Spec . Impact of COVID-19-Mediated Olfactory Loss on Quality of Life

tetano

Editor, Senior Moderator
ORL J Otorhinolaryngol Relat Spec


. 2022 Apr 12;1-6.
doi: 10.1159/000523893. Online ahead of print.
Impact of COVID-19-Mediated Olfactory Loss on Quality of Life


Martin Sylvester Otte[SUP] 1 [/SUP], Antje Haehner[SUP] 2 [/SUP], Marie-Luise Bork[SUP] 1 [/SUP], Jens Peter Klussmann[SUP] 1 3 [/SUP], Jan Christoffer Luers[SUP] 1 [/SUP], Thomas Hummel[SUP] 2 [/SUP]



Affiliations

Abstract

Introduction: COVID-19 can be associated with a variety of longer-lasting impairments that can have a significant impact on patients' quality of life (QoL). While this is well described in the literature for limitations in lung capacity or permanent headaches, there is little research on the impact of olfactory dysfunction in the context of COVID-19 on patients' QoL.
Methods: In 65 patients with a history of COVID-19, the present olfactory ability was assessed using the Sniffin' Sticks test. In addition, olfactory QoL was assessed by the Questionnaire of Olfactory Disorders. Self-assessment was performed with visual analogue scales. The data were compared with the results obtained in healthy individuals and in patients with hyposmia due to other viral infections.
Results: The QoL of COVID-19 patients was significantly lower compared to the healthy control group. Even recovered subjects whose olfaction had already returned to the normal range still had a reduced QoL. The severity of the olfactory impairment correlated with the reduction in QoL. However, the olfactory QoL of COVID-19 patients was not worse than that of patients' olfactory loss due to other viral infections. Patients with parosmia had reduced QoL and rated their situation worse than patients without parosmia.
Conclusion: QoL appears to be impaired in patients with long-lasting COVID-19 olfactory disorders several months after overcoming acute symptoms, even if olfaction has normalized. However, the impairment is not more pronounced than in patients with other postviral olfactory disorders of the same duration.

Keywords: Coronavirus disease 2019; Quality of life; Severe acute respiratory syndrome coronavirus 2; Smell disorders; Sniffin’ sticks.
 
Back
Top Bottom